High-dimensional profiling following third MMR vaccination or mumps virus infection reveals individuals with suboptimal immunity
René H. M. Raeven, Martijn Vos, Maarten E. Emmelot, Petra Molenaar, Irina Tcherniaeva, Hinke I. ten Hulscher, Sara Suarez Hernandez, Patricia Kaaijk · 2026
Read High-dimensional profiling following third MMR vaccination or mumps virus infection reveals individuals with suboptimal immunity by René H. M. Raeven, Martijn Vos, Maarten E. Emmelot, Petra Molenaar, Irina Tcherniaeva, Hinke I. ten Hulscher, Sara Suarez Hernandez, Patricia Kaaijk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13615980.txt.
Description
René H. M. Raeven and colleagues compare in 2026 the immune response to a third MMR vaccine dose against the response to a natural mumps infection in young adults. People vary widely in how strongly they answer a vaccine, and spotting weak responders early matters for protecting them. The team used a many-parameter analysis of blood and immune cells after the third measles, mumps, and rubella shot.
The booster raised antibodies, antibody-making B cells, and helper T cells against mumps. Real infection produced the same kinds of response, only stronger, and added a robust killer T cell response the shot lacked. High-dimensional cell profiling also split people into low and high responder groups with distinct patterns, and certain memory T cells tracked with a strong booster answer. Such markers could guide extra doses to those who need them.
Catalog record
| CREATOR | René H. M. Raeven, Martijn Vos, Maarten E. Emmelot, Petra Molenaar, Irina Tcherniaeva, Hinke I. ten Hulscher, Sara Suarez Hernandez, Patricia Kaaijk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |